| |
08/09/2010 |
 |
AlphaVax’s Vector System Shows Potential for Cancer Immunotherapy
click here >>
|
01/19/2010 |
|
AlphaVax Advances Filovirus Biodefense Vaccines
click here >>
|
11/04/2009 |
|
AlphaVax Progresses a Prophylactic HSV Vaccine
click here >>
|
09/01/2009 |
|
AlphaVax Progresses H1N1 Influenza Vaccine
click here >>
|
07/17/2009 |
|
AlphaVax Announces Results from Initial Testing of its H1N1 (Swine) Influenza Vaccine
click here >>
|
05/28/2009 |
|
2009 IBC Meeting
click here >>
|
05/14/2009 |
|
AlphaVax Announces Phase I/II Study of Active Cancer Immunotherapy
click here >>
|
05/13/2009 |
|
AlphaVax Announces Promising Results in Melanoma Studies
click here >>
|
02/16/2009 |
|
AlphaVax Announces New Vice President of Regulatory, Quality and Clinical Operations
click here >>
|
12/29/2008 |
|
Novartis enters into exclusive agreement with AlphaVax for novel CMV vaccine candidate
click here >>
|
10/29/2008 |
|
AlphaVax Presents Results from CMV Phase 1 Trial
click here >>
|
07/21/2008 |
|
AlphaVax Announces Initiation of Chlamydia Vaccine Program
click here >>
|
06/06/2008 |
|
AlphaVax Continues to Expand the Use of its Vaccine Platform
click here >>
|
04/17/2008 |
|
AlphaVax Announces Initial Analysis of Data from CMV Phase 1 Clinical Trial
click here >>
|
01/30/2008 |
|
AlphaVax Announces New CMV Advisory Board
click here >>
|
10/31/2007 |
|
AlphaVax Announces Results from Phase 1 Influenza Vaccine Clinical Trial
click here >>
|
07/30/2007 |
|
AlphaVax Announces Interim Results from Phase 1 Influenza Vaccine Clinical Trial
click here >>
|
07/10/2007 |
|
AlphaVax Announces $3.6M Award to Develop New Adjuvant Technologies for Vaccines
click here >>
|
04/11/2007 |
|
AlphaVax begins Clinical Trials with Vaccines for CMV and FLU
click here >>
|
03/13/2007 |
|
In The Pipeline
click here >>
|
02/19/2007 |
|
New Data Support AlphaVax's Vaccine for CMV
click here >>
|
02/02/2007 |
|
AlphaVax Announces the Closing of its E Series Investment Offering
click here >>
|
01/29/2007 |
|
AlphaVax Announces Clinical Trials for Influenza and CMV
click here >>
|
10/11/2006 |
|
Parents of EEE victim raising money for disease research
click here >>
|
09/06/2006 |
|
AlphaVax Announces Phase 1 Clinical Trial Results
click here >>
|
07/26/2006 |
|
AlphaVax Granted Key Vaccine Manufacturing Patent in US
click here >>
|
05/10/2006 |
|
Three NCBIO members serving on National BIO Committees
click here >>
|
04/05/2006 |
|
Peter Young to Testify on BioShield
click here >>
|
11/11/2005 |
|
The Triangle’s Fastest Growing Private Biotech Company
click here >>
|
10/21/2005 |
|
Alphavax Announces Support of Senator Richard Burr's Legislation
click here >>
|
10/19/2005 |
|
Alphavax Announces $3.3 Million Grant Award to Develop A Smallpox Vaccine
click here >>
|
06/03/2005 |
|
AlphaVax Announces New Lease for Vaccine Manufacturing Operations
click here >>
|
05/01/2005 |
|
Peter Young elected Chair of NCBIO
click here >>
|
04/10/2005 |
|
AlphaVax Annouces NIH Award for Influenza Vaccine
click here >>
|
02/06/2005 |
|
Gene Vaccine Protects Mice Against Development of Her2/neu Breast Cancer
click here >>
|
11/17/2004 |
|
AlphaVax Annouces $4.8m Award for a SARS Vaccine
click here >>
|
06/04/2004 |
|
AlphaVax Annouces New Vice President of Development
click here >>
|
03/25/2004 |
|
AlphaVax Annouces New Manufacturing Initiative
click here >>
|
11/19/2003 |
|
AlphaVax Names Jonathan Smith Chief Scientific Officer
click here >>
|
10/21/2003 |
|
AlphaVax Annouces New $16.8 Million NIH Award
click here >>
|
09/05/2003 |
|
AlphaVax Receives Two NIH Biodefense Grants
click here >>
|
08/22/2003 |
|
AlphaVax Begins Human Clinical Trials of Novel Vaccine Technology
click here >>
|
07/12/2003 |
|
Progenics and Cytogen Develop Novel Prostate Cancer Vaccine with AlphaVax
click here >>
|
06/26/2003 |
|
AlphaVax Hires New Medical Director
click here >>
|
05/15/2003 |
|
AlphaVax Annouces New Head of Discovery and New Facility
click here >>
|
04/03/2002 |
|
AlphaVax Annouces $11 million in Series C
click here >>
|
03/04/2002 |
|
AlphaVax signs Manufacturing Agreement
click here >>
|
02/28/2001 |
|
AlphaVax announces $8.2 million in Series B
click here >>
|
02/03/2001 |
|
Glaxo Wellcome VP, Peter F. Young, named as President of AlphaVax
click here >>
|
11/19/2000 |
|
International AIDS Vaccine Initiative Announces Major Research Partnership with AlphaVax
click here >>
|